XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment from accounting changes
Series A Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative-effect adjustment from accounting changes
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from accounting changes
Accumulated Other Comprehensive Loss
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2020     40,000            
Redeemable convertible preferred stock beginning balance at Dec. 31, 2020     $ 39,823            
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of convertible preferred stock, net (in shares)     0            
Issuance of convertible preferred stock, net     $ 45            
Redeemable convertible preferred stock ending balance (in shares) at Dec. 31, 2021     40,000            
Redeemable convertible preferred stock ending balance at Dec. 31, 2021     $ 39,868            
Balance, beginning of period (in shares) at Dec. 31, 2020       103,000,594          
Balance, beginning of period at Dec. 31, 2020 $ 590,557     $ 103 $ 860,556   $ (270,313)   $ 211
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock as dividend on convertible preferred stock (in shares)       122,560          
Issuance of common stock pursuant to employee stock purchase plan (in shares)       334,248          
Issuance of common stock pursuant to employee stock purchase program 13,787       13,787        
Issuance of common stock pursuant to exercise of stock options (in shares)       1,709,324          
Issuance of common stock pursuant to exercise of stock options 8,980     $ 2 8,978        
Issuance of common stock pursuant to settlement restricted stock units (in shares)       1,559,425          
Issuance of common stock pursuant to settlement of restricted stock units 0     $ 2 (2)        
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (in shares)       (458,152)          
Common stock surrendered for employees' tax liability upon settlement of restricted stock units $ (27,067)     $ (1) (27,066)        
Issuance of common stock in connection with repurchase of convertible senior notes (in shares) 0                
Cumulative-effect adjustment from accounting changes       $ 0          
Purchases of capped calls related to convertible senior notes $ 62,647       62,647        
Issuance of common stock in connection with conversion of convertible senior notes (in shares)       40,768          
Issuance of common stock in connection with conversion of convertible senior notes (63)       (63)        
Stock-based compensation 58,781       58,781        
Other comprehensive income (385)               (385)
Net loss (109,613)           (109,613)    
Balance, end of period (in shares) at Dec. 31, 2021       106,308,767          
Balance, end of period at Dec. 31, 2021 $ 309,852 $ (162,478)   $ 106 682,084 $ (170,240) (372,164) $ 7,762 (174)
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of convertible preferred stock, net     $ 46            
Redeemable convertible preferred stock ending balance (in shares) at Dec. 31, 2022 40,000   40,000            
Redeemable convertible preferred stock ending balance at Dec. 31, 2022 $ 39,914   $ 39,914            
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock as dividend on convertible preferred stock (in shares)       122,560          
Issuance of common stock pursuant to employee stock purchase plan (in shares)       1,170,106          
Issuance of common stock pursuant to employee stock purchase program 6,465     $ 1 6,464        
Issuance of common stock pursuant to exercise of stock options (in shares)       700,333          
Issuance of common stock pursuant to exercise of stock options 4,987     $ 1 4,986        
Issuance of common stock pursuant to settlement restricted stock units (in shares)       1,972,441          
Issuance of common stock pursuant to settlement of restricted stock units 0     $ 2 (2)        
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (in shares)       (578,029)          
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (7,498)     $ 0 (7,498)        
Stock-based compensation 71,917       71,917        
Other comprehensive income (627)               (627)
Net loss $ (321,143)           (321,143)    
Balance, end of period (in shares) at Dec. 31, 2022 109,696,178     109,696,178          
Balance, end of period at Dec. 31, 2022 $ 63,953     $ 110 757,951   (693,307)   (801)
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of convertible preferred stock, net     $ 45            
Redeemable convertible preferred stock ending balance (in shares) at Dec. 31, 2023 40,000   40,000            
Redeemable convertible preferred stock ending balance at Dec. 31, 2023 $ 39,959   $ 39,959            
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock as dividend on convertible preferred stock (in shares)       122,560          
Issuance of common stock pursuant to employee stock purchase plan (in shares)       1,491,040          
Issuance of common stock pursuant to employee stock purchase program $ 7,201     $ 1 7,200        
Issuance of common stock pursuant to exercise of stock options (in shares) 801,866     801,866          
Issuance of common stock pursuant to exercise of stock options $ 2,412     $ 1 2,411        
Issuance of common stock pursuant to settlement restricted stock units (in shares)       6,955,493          
Issuance of common stock pursuant to settlement of restricted stock units 0     $ 7 (7)        
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (in shares)       (1,694,966)          
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (16,349)     $ (2) (16,347)        
Stock-based compensation 74,938       74,938        
Other comprehensive income 619               619
Net loss $ (130,026)           (130,026)    
Balance, end of period (in shares) at Dec. 31, 2023 117,372,171     117,372,171          
Balance, end of period at Dec. 31, 2023 $ 2,748     $ 117 $ 826,146   $ (823,333)   $ (182)